Information Provided By: 
Fly News Breaks for February 8, 2016
PKI
Feb 8, 2016 | 08:21 EDT
After PerkinElmer's stock fell 18% over the last month, Cantor says that the company is continuing to benefit from the strong biopharma market. The firm expects the company to benefit from strong growth of its China diagnostics business this year, and it expects the company's revenue and EPS growth to accelerate over the longer term. Cantor cut its price target o nthe name to $59 from $62 but keeps a Buy rating on the shares.
News For PKI From the Last 2 Days
There are no results for your query PKI
